Medicare could waste up to $605 million per year on the controversial Alzheimer's drug aducanumab if it is eventually approved for widespread use because it is supplied in vials containing fixed doses that may not be appropriate ...
Jun 27, 2022
1
13
A new data-driven mechanistic approach that predicts cell types within tissue will help to reduce drug costs and treat diseases that were difficult to develop drugs for, according to a West Virginia University scientist.
Apr 14, 2022
0
6
Katherine Stewart, 16, must take six to 10 insulin shots a day to properly manage her type 1 diabetes.
Mar 14, 2022
0
5
Last October, the U.S. Food and Drug Administration (FDA) finalized a set of short-term, voluntary goals for lowering salt levels in foods—five years after they were proposed in 2016. A new study published today in Hypertension—a ...
Feb 21, 2022
0
8
Health economist Peter Neumann has a proposal for how to rein in the growing costs of prescription drugs.
Jan 28, 2022
1
4
Biogen is slashing the price of its Alzheimer's treatment in half months after it debuted to widespread criticism for an initial cost that could reach $56,000 annually.
Dec 20, 2021
0
5
Aduhelm, the first new Alzheimer's drug in 18 years, could easily become the best-selling drug in Medicare, despite its potential massive cost and tremendous uncertainty about whether the drug even works, says Rachel Sachs, ...
Dec 7, 2021
1
3
(HealthDay)—Nearly 13 million U.S. adults a year skip or delay filling needed prescriptions due to high price tags, new research shows.
Dec 3, 2021
0
2
(HealthDay)—Patient economic burden associated with cancer care was projected to be $21.1 billion in 2019, according to a report published online Oct. 26 in the Journal of the National Cancer Institute.
Nov 8, 2021
0
1
Health regulators on Tuesday unveiled their proposal to allow Americans to buy hearing aids without a prescription, a long-awaited move intended to make the devices more accessible to millions of people with hearing problems.
Oct 19, 2021
0
2
